Igene Biotechnology Other Current Liabilities

Igene Biotechnology (IGNE) currently reports a other current liabilities of $520K as of September 2010. That compares with $440K in the prior-year period — up 17.1% year over year. Use the charts on this page to explore Igene Biotechnology's other current liabilities history and peer comparisons.

Igene Biotechnology's other current liabilities increased from $440K to $520K — a 17.1% year-over-year increase (period ending September 2010). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Igene Biotechnology reported $520K in other current liabilities as of September 2010. That compares with $440K in the prior-year period — up 17.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $520K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Igene Biotechnology, and consider following IGNE for alerts when major investors trade the stock.